BMY

5 Top Stock Trades for Friday: UBER, FB, BMY, MU, TWLO

By Bret Kenwell, InvestorPlace Contributor
Bristol-Myers Squibb, Uber, Facebook, Micron and Twilio were our top stock trades for Friday. That said, let's look at the charts now.

Bristol-Myers Squibb Earnings: BMY Stock Jumps 2% on Q2 Beats

By Nick Clarkson, Web Editor
Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.

Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings

By David Moadel, InvestorPlace Contributor
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.

Bristol-Myers Squibb Has Great Potential Ahead of Earnings

By Mark R. Hake, CFA
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.

5 Healthcare Stocks for Good (Portfolio) Health

By Vince Martin, InvestorPlace Contributor
These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.

Undervalued Bristol-Myers Squibb Stock Is Worth 50% More

By Mark R. Hake, CFA
BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.

10 Value Stocks to Keep on Your Short List

By Vince Martin, InvestorPlace Contributor
Value stocks have been out of favor for some time — but that will change at some point. When it does, these 10 names should be winners.

5 Healthcare Stocks That Are Profitable but Also Cheap

By Mark R. Hake, CFA
These five healthcare stocks have low P/E ratios and ample yields, making them cheap and profitable options for investors.

3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline

By David Moadel, InvestorPlace Contributor
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.

3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb

By David Moadel, InvestorPlace Contributor
Tuesday's big stock charts feature health-care-sector names that may offer value and leadership.

5 Top Stock Trades for Wednesday: AMZN, DKS, AAL, BMY, UAL

By Bret Kenwell, InvestorPlace Contributor
Amazon, Dick's Sporting Goods, American Airlines, United Airlines and Bristol-Myers Squibb were our top stock trades for Wednesday.

3 Healthcare Stocks Under Pressure from Bernie

By William Roth, InvestorPlace Market Strategist
These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.

Is Amarin Stock a Top Pick for 2020?

By Bret Kenwell, InvestorPlace Contributor
Amarin stock has been on fire in 2019, but the reaction to its latest news was discouraging. Is that a buying opportunity or a warning sign?

Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth

By Tyler Craig, Tales of a Technician
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.

Stock Market Today: New Highs; Buy Micron, Nvidia?

By Bret Kenwell, InvestorPlace Contributor
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.

4 Top Stock Trades for Monday: GS, BIG, BMY

By Bret Kenwell, InvestorPlace Contributor
Goldman Sachs, Bristol-Myers Squibb, Zoom Video and Big Lots were our top stock trades from Friday.

Thursday’s Vital Data: Bristol-Myers Squibb, Shopify and Walmart

By Tyler Craig, Tales of a Technician
Options trading was buzzing in Bristol-Myers Squibb, Shopify and Walmart stock on Wednesday. Here are the metrics that matter moving forward.

4 Top Stock Trades for Tuesday: ROKU, GOGO, BAC, BMY

By Bret Kenwell, InvestorPlace Contributor
Roku, Bristol-Myers Squibb, Bank of America and Gogo were our top stock trades for Tuesday. Here's a look at the charts.

10 Stocks Owned by the World’s Richest and Most Powerful

By Will Ashworth, InvestorPlace Contributor
Billionaire-owned companies perform twice as well as others. Turns out the world's wealthiest and most powerful make for good investors.
Load More